Indices
AlphaTrack: Suggested Signals & Set Ups – 25 November 2025
AlphaTrack delivers sharp, forward-looking insights for traders who want to stay ahead of market momentum. We focus primarily on long setups in bullish cycles, treating orderly pullbacks as potential opportunities rather than panic signals. Each post blends clean technical setups, key catalysts, and disciplined analysis to help readers navigate the noise and spot conviction-worthy entries. Clear, practical, and built for traders who trade with intent, not emotion.

Thoughtful insights and approachable analysis.
Quick Market Overview
U.S. stocks opened the holiday week on firmer ground, with tech leading a broad rebound that briefly lifted the gloom of what is still shaping up to be the S&P 500’s worst November since the financial crisis. Strong earnings, particularly from Big Tech, and renewed enthusiasm around AI helped improve sentiment, with Gemini 3’s strong debut adding to the upbeat tone. With third-quarter profits running well ahead of expectations and key consumer data due before the Thanksgiving lull, investors found more reasons for optimism than they had just a week earlier.
General Market Health (SPX500)

The SPX500 has struggled through November, with a lower peak (3) followed by a lower trough (4) underscoring the weakness. The index now appears to be stabilising, potentially finding support. The RSI is edging towards a break above 50, which would tilt momentum back into positive territory, while the EMAs are converging (arrow) and approaching a bullish crossover. That crossover would be encouraging and may hint at participants beginning to buy the dip, but the decisive signal for us remains the RSI: a move above 50, and the ability to hold it, would be the most convincing bullish development.
Potential Trade Setups
We’re still watching to see whether buy-the-dip opportunities fully materialise. Below are some of the more compelling candidates so far. If support holds, we’ll continue scanning for additional names that begin to show improving technicals and emerging opportunity.
Apple (AAPL)

The AAPL chart carries a constructive tone. The RSI is holding above 50, signalling underlying positive momentum, and the EMAs have already formed a bullish crossover. Price is now pressing against overhead resistance near $275; a decisive break above this level would be a favourable development. If the RSI can remain above 50, the odds improve that this resistance will give way, paving the path for further gains.
Apple’s premium valuation reflects a growth share, fuelled by a strong iPhone 17 launch and the expanding weight of high-margin services. Revenue has re-accelerated across hardware and services in 2025, with the latest iPhone line already supply-constrained ahead of the holiday quarter. Services now account for nearly a third of sales and earn roughly double the margin of hardware, pushing the business towards more stable, higher-quality recurring revenue. Management expects double-digit growth into early 2026, and a clearer AI roadmap, from enhanced on-device features to a revitalised Siri, adds another upgrade catalyst. The shares are not cheap, but the underlying momentum still appears well supported.
3M Company (MMM)

The 3M chart is turning constructive. The RSI remains above 50, and the longer it holds that level, the stronger the case for further upside. The daily chart has also posted a higher trough, a favourable sign, while the EMAs have crossed bullishly. If they begin to show clear angle and separation, MMM is likely to challenge and potentially break the overhead resistance near $173. A move above that level would establish a higher peak alongside the higher trough, confirming an emerging uptrend. Volume, though not shown here, has been supportive and points to ongoing accumulation in 3M Company.
3M shares climbed after a solid third quarter and a small guidance upgrade, but the more important story is the operational turnaround taking shape under CEO Bill Brown. Most of the 3.2% organic growth surprise came from “self-help” efforts: better commercial execution, improved asset use and a stronger product-launch pipeline. With these initiatives still early, confidence is growing that 3M can rebuild momentum across its industrial and consumer businesses as demand recovers. Nearly 200 new products have been released this year, with an even higher target for 2025, signalling real progress. Recent analyst upgrades reflect mounting belief that the improvements are beginning to stick.
The PNC Financial Services Group (PNC)

PNC has lagged through 2025, down just over 2% year-to-date, but the chart is beginning to show signs of recovery. Price has broken above overhead resistance near $188, and the RSI has pushed above 50, a level it will need to hold to unlock further upside. The OBV is also improving, hinting at early accumulation. The EMAs have crossed bullishly, and if they begin to show stronger angle and separation, it would reinforce the breakout and support a move above this key resistance zone.
PNC has doubled its branch-investment budget to roughly $2 billion as it accelerates its push into fast-growing U.S. markets and strengthens its deposit base. The bank plans to open 300 branches over five years, triple its initial target, while refurbishing its entire network and hiring more than 2,000 staff by 2030. Management argues that reaching a 7% local branch share is crucial for stronger sales, and the expansion aims to give PNC meaningful scale across its key markets. With competitors also moving aggressively into the Southeast and Southwest, PNC is pursuing both organic growth and acquisitions to secure prime locations. Analyst sentiment remains constructive: Oppenheimer has reiterated its Outperform rating, with an average target of about $226 implying roughly 25% upside and expectations for solid revenue and earnings growth into 2026.
UCB S.A. (XBRU: UCB)

UCB SA’s EMAs are in a bullish configuration, and the RSI is holding above 50, signalling underlying positive momentum. The OBV also points to accumulation. If the RSI can stay above 50, that momentum support should help pave the way for further gains in the share price.
Barclays analyst Charles Pitman, CFA, has reiterated a Buy rating on UCB SA with a €270 price target. UBS also reaffirmed its Buy stance in a 10 November report, setting a price target of €300. UCB SA is currently trading around €234.
We’re Here to Help You Trade with Confidence
Have a question? Our team of experienced professionals is available 24/5 to assist.
Get in touch today and let us help you make the most of your trading journey.
Hot News, Cold Logic
November has been punishing for markets, with the S&P 500 and Nasdaq slipping, volatility rising and Bitcoin dropping more than 20% despite Nvidia’s standout results. Concerns over stretched valuations and excessive risk-taking have driven the pullback, though a potential rebound, helped by fresh highs in Alphabet and a strong Nvidia recovery, will suggest sentiment may be stabilising. Some strategists argue that a cooling in the AI trade could actually reinforce the broader bull market into 2026, and history shows December often performs well after a weak November. Whether that pattern repeats will hinge on upcoming retail data and the Fed’s early-December decision.
Final Thought
Markets remain in a delicate phase. Global equities have edged higher on renewed Fed rate-cut hopes, yet growing doubts over AI valuations and softer macro data continue to restrain risk appetite. Even so, the underlying support seemingly hasn’t disappeared, leaving room for a cautiously constructive outlook for investors willing to look for opportunities.

Senior Market Specialist
Russell Shor
Russell Shor is a Senior Market Strategist at Tradu, having been promoted to the role in 2025 in recognition of his depth of insight and consistent delivery of high-impact market analysis. He originally joined FXCM in October 2017 as a Senior Market Specialist.
Russell holds an Honours Degree in Economics from the University of South Africa, is a certified FMVA®, and a full member of the Society of Technical Analysts (UK). With over 20 years of experience in financial markets, his work is renowned for its clarity, precision, and strategic value across asset classes.